GOLDMAN SACHS GROUP INC

Position in ARQT — Arcutis Biotherapeutics, Inc.

CIK 886982 NEW YORK, NY

Back to ARQT Full portfolio

Position in ARQT

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$37,766,984

-$8,012,048 QoQ

Shares Held

1,603,013

+1.7% QoQ

Ownership

1.28%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 99.9470996180318.ToString("F0")% Shared 0.ToString("F0")% None 0.05290038196820613.ToString("F0")%

Common Shares in ARQT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

GOLDMAN SACHS GROUP INC holds $10,297,038,010 across 364 Biotechnology names. ARQT ranks #63 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	2,417,875	$1,079,677,898
2	REGN	Regeneron Pharmaceuticals, Inc.	1,300,558	$1,004,863,129
3	MRNA	Moderna, Inc.	6,603,697	$335,467,805
4	ROIV	Roivant Sciences Ltd.	11,111,591	$307,791,069
5	PRAX	Praxis Precision Medicines, Inc.	710,734	$228,991,385
6	INCY	Incyte Corp	2,351,221	$221,296,919
7	RVMD	Revolution Medicines, Inc.	2,185,500	$212,539,874
8	RYTM	Rhythm Pharmaceuticals, Inc.	1,965,432	$170,933,620

All Filings in ARQT

Export CSV

25 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$37,766,984	1,603,013	+1.7%	Shares	Defined	2026-05-15
2025-12-31	$45,779,032	1,576,413	-12.7%	Shares	Defined	2026-03-25
2025-09-30	$34,024,022	1,804,988	-4.5%	Shares	Defined	2025-11-14
2025-06-30	$26,501,247	1,890,246	+71.3%	Shares	Defined	2025-08-14
2025-03-31	$17,257,377	1,103,413	-15.5%	Shares	Defined	2025-06-27
2024-12-31	$18,194,905	1,306,167	-17.8%	Shares	Defined	2025-02-11
2024-09-30	$14,785,901	1,589,882	+96.9%	Shares	Defined	2024-11-14
2024-06-30	$7,508,205	807,334	+0.1%	Shares	Defined	2024-08-13
2024-03-31	$7,992,652	806,524	+10.0%	Shares	Defined	2024-05-15
2023-12-31	$2,367,595	733,002	+120.1%	Shares	Defined	2024-05-14
2023-09-30	$1,768,282	333,010	-52.0%	Shares	Defined	2024-05-15
2023-06-30	$6,616,877	694,321	+181.1%	Shares	Defined	2024-05-14
2023-03-31	$2,716,736	246,976	-11.7%	Shares	Defined	2024-05-14
2022-12-31	$4,139,041	279,665	+52.6%	Shares	Defined	2024-05-14
2022-09-30	$3,502,804	183,297	+90.6%	Shares	Defined	2024-05-14
2022-06-30	$2,049,553	96,178	+53.7%	Shares	Defined	2024-05-14
2022-03-31	$1,205,155	62,573	+29.7%	Shares	Defined	2022-05-16
2021-12-31	$1,000,372	48,234	+18.7%	Shares	Defined	2022-02-17
2021-09-30	$970,578	40,627	+27.9%	Shares	Defined	2022-01-20
2021-06-30	$866,702	31,759	+48.4%	Shares	Defined	2021-08-13
2021-03-31	$619,015	21,397	-90.5%	Shares	Defined	2021-05-17
2020-12-31	$6,322,638	224,765	+25.3%	Shares	Defined	2021-02-12
2020-09-30	$5,255,716	179,376	+4.3%	Shares	Defined	2020-11-13
2020-06-30	$5,198,679	171,914	-13.9%	Shares	Defined	2020-08-12
2020-03-31	$5,948,973	199,630	—	Shares	Defined	2020-05-15
No filing history on record for this holder in this stock.